Strategic partnership between Genedata and SCIEX deepens and accelerates characterization of next generation biotherapeutics

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process. July 29, 2021 Framingham, MA, USA and Basel, Switzerland — SCIEX, a global leader in life science analytical technologies, and Genedata, leading provider of biopharma enterprise software solutions, have entered into a strategic partnership to develop new software... Read more

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute

06/28/21 Project Explores LC-MS Data Analytics Methods to Rapidly Characterize Complex Biomolecules NEWS SUMMARY: Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research. Projects include developing analytical workflows for nucleic acid therapeutic products and bioinformatics research to deliver robust and accurate identification for a variety of... Read more

PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech

Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 22, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene... Read more

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Changzhou, China, operations become Avantor’s first single-use production facility in AMEA region; doubles Avantor’s global single-use cleanroom space Adds proprietary technologies to Avantor’s bioprocessing manufacturing capabilities to meet growing global demand for single-use solutions RADNOR, Pa. and SHANGHAI, June 1, 2021 /PRNewswire/ —  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the... Read more

Pivotal Phase III data at ASCO show Roche’s Tecentriq helps certain people with early lung cancer live significantly longer without their disease returning

Tecentriq improved disease-free survival by more than one-third in people with PD-L1-positive resectable early-stage lung cancer, compared with best supportive care First and only cancer immunotherapy to show positive Phase III results in the adjuvant lung cancer setting New adjuvant treatment options are urgently needed in early lung cancer to help the approximately 50% of... Read more

Bio-Techne and 908 Devices Announce Joint Collaboration

MAY 04, 2021 MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple... Read more

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society WALTHAM, Mass. (April 28, 2021) — Thermo Fisher Scientific Inc. has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval... Read more

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

About 90,000 women globally die from endometrial cancer each year1 VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly) Roche/GSK collaboration represents an important step towards a personalised healthcare strategy that can help identify patients who are most likely to benefit from a... Read more